can you use sglt2 and glp 1 together Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM) | Cardiovascular Diabetology GLP1 Receptor Agonists vs SGLT2-I

Table 7: Results at Week 26 in a Trial Comparing TRESIBA Dosed Once Daily at the Same and at Alternating Times Each Day to Insulin Glargine U-100 in Adult Patients with Type 1 Diabetes Mellitus Receiving Insulin Aspart at Mealtimes Type 1 Diabetes Pediatric Patients 1 Year of Age and Older Study J TRESIBA Administered at the Same Time Each Day in Combination with a Rapid Acting Insulin Analog at Mealtimes in Pediatric Patients 1 Year of Age and Older The efficacy of TRESIBA was evaluated in a 26 week, randomized, open label, multicenter trial in 350 patients with type 1 diabetes mellitus (Study J)

Free cobalamin is released from the intestinal enterocytes to the blood via TC-Cbl interaction with a basolateral membrane transporter that is a member of the ATP-binding cassette family of transporters, specifically the ABCC1 transporter

Sources: Kraus D, et al

Potential Benefits of IGF-1 LR3 India IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified version of IGF-1, designed to enhance stability and effectiveness